惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

GbyAI
GbyAI
Y
Y Combinator Blog
F
Fortinet All Blogs
H
Hackread – Cybersecurity News, Data Breaches, AI and More
N
Netflix TechBlog - Medium
T
Tailwind CSS Blog
aimingoo的专栏
aimingoo的专栏
博客园 - Franky
T
The Blog of Author Tim Ferriss
D
DataBreaches.Net
量子位
博客园 - 三生石上(FineUI控件)
I
InfoQ
Engineering at Meta
Engineering at Meta
WordPress大学
WordPress大学
阮一峰的网络日志
阮一峰的网络日志
爱范儿
爱范儿
D
Docker
美团技术团队
雷峰网
雷峰网
U
Unit 42
Stack Overflow Blog
Stack Overflow Blog
Recent Announcements
Recent Announcements
人人都是产品经理
人人都是产品经理

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Nolato AB (publ) (NLTBF) Q1 2026 Earnings Call Transcript
2026-05-07 · via All Articles on Seeking Alpha

Nolato AB (publ) (NLTBF) Q1 2026 Earnings Call May 6, 2026 7:30 AM EDT

Company Participants

Christer Wahlquist - President, CEO & Interim President of Industrial Solutions
Per-Ola Holmström - Executive VP & CFO

Conference Call Participants

Adrian Gilani Göransson - ABG Sundal Collier Holding ASA, Research Division
Oscar Ronnkvist - SEB, Research Division
Anders Akerblom - Nordea Markets, Research Division
Mikael Laséen - DNB Carnegie, Research Division

Presentation

Operator

Hello, and welcome to today's presentation with Nolato, where CEO, Christer Wahlquist; and CFO, Per-Ola Holmstrom, will present the report for the first quarter of 2026. [Operator Instructions] And with that said, I hand over the word to you guys.

Christer Wahlquist
President, CEO & Interim President of Industrial Solutions

Thank you, and welcome to the presentation of Nolato's first quarter of 2026. Christer Wahlquist speaking here and starting on Page 2. The first quarter -- during the first quarter of 2026, we saw growth in both our business areas despite a very volatile geopolitical situation. The total organic growth, if we adjust for currency, ended up at 3% and it was a little bit stronger on the medical side with 5% and 1% on the engineered side.

That summarizes to an EBITA of SEK 260 million. And of course, the EBITDA was strongly affected by currency headwinds as we calculate to 7%. We kept our margins on 11% and sustaining them in a good way. And of course, our strong financial position with very good possibilities to execute our acquisition agenda remains.

Turning to Page 3, summarizing the Nolato group. The group consists of 2 business areas, the Medical Solutions at 57% of the total and Engineered Solutions at 43%. Of course, it's 2 different markets. But behind the scenes, we are doing similar things, of course, with some different growth drivers and the different key needed things. But the 2 business